Stocktoria
Koninklijke Philips N.V. PHIA.AS
NL · Euronext Amsterdam · XAMS · stock · Healthcare · website
Koninklijke Philips N.V. financials (annual, from 10-K)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $17.8B | $18.0B | $18.2B | $17.8B |
| Gross profit | $8.1B | $7.8B | $7.4B | $7.2B |
| R&D expense | $1.7B | $1.7B | $1.9B | $2.1B |
| SG&A expense | $5.0B | $5.1B | $5.1B | $5.3B |
| Operating income | $1.4B | $513.0M | -$168.0M | -$177.0M |
| Interest expense | $294.0M | $337.0M | $306.0M | $244.0M |
| Income tax | $282.0M | $963.0M | -$73.0M | -$113.0M |
| Net income | $895.0M | -$702.0M | -$466.0M | -$1.6B |
| EPS (diluted) | $0.94 | $-0.75 | $-0.49 | $-1.68 |
| Operating cash flow | $1.2B | $1.6B | $2.1B | -$173.0M |
| Free cash flow | $504.0M | $893.0M | $1.5B | -$979.0M |
| Cash & equivalents | $2.8B | $2.4B | $1.9B | $1.2B |
| Inventory | $2.9B | $3.2B | $3.5B | $4.0B |
| Total assets | $26.9B | $29.0B | $29.4B | $30.7B |
| Total liabilities | $16.0B | $16.9B | $17.3B | $17.4B |
| Shareholders' equity | $11.0B | $12.0B | $12.0B | $13.2B |
Growth · year-over-year
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | -1.0% | -0.8% | +1.9% | — |
| Free cash flow growth | -43.6% | -40.1% | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: company filings via Yahoo Finance · NL · as of 2025-12-31. Figures in EUR; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.